Moore Capital Management LP bought a new position in Danaher Corporation (NYSE:DHR – Free Report) in the 4th quarter, HoldingsChannel.com reports. The firm bought 103,676 shares of the conglomerate’s stock, valued at approximately $23,734,000.
Several other institutional investors have also recently made changes to their positions in the company. State Street Corp grew its stake in shares of Danaher by 1.7% in the 4th quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock worth $6,345,529,000 after acquiring an additional 472,608 shares in the last quarter. Capital International Investors grew its position in Danaher by 8.9% during the fourth quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock valued at $4,177,386,000 after buying an additional 1,487,768 shares during the period. Price T Rowe Associates Inc. MD grew its position in Danaher by 9.1% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock valued at $3,656,595,000 after buying an additional 1,334,221 shares during the period. Norges Bank bought a new position in Danaher during the fourth quarter valued at about $2,177,106,000. Finally, Generation Investment Management LLP grew its position in Danaher by 14.1% during the fourth quarter. Generation Investment Management LLP now owns 7,589,661 shares of the conglomerate’s stock valued at $1,737,425,000 after buying an additional 934,995 shares during the period. Institutional investors own 79.05% of the company’s stock.
Danaher Price Performance
Shares of NYSE:DHR opened at $177.85 on Thursday. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $125.88 billion, a PE ratio of 34.40, a P/E/G ratio of 2.31 and a beta of 0.81. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a 50-day moving average price of $180.26 and a two-hundred day moving average price of $203.59.
Danaher Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is currently 30.95%.
Wall Street Analyst Weigh In
Several equities analysts recently weighed in on the stock. Evercore increased their price target on shares of Danaher from $225.00 to $232.00 and gave the company an “outperform” rating in a research report on Tuesday, April 21st. JPMorgan Chase & Co. reduced their price target on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Morgan Stanley reduced their price target on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Jefferies Financial Group restated a “buy” rating and set a $245.00 price target on shares of Danaher in a research report on Tuesday, April 21st. Finally, Rothschild & Co Redburn set a $205.00 price target on shares of Danaher in a research report on Friday, April 17th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $233.61.
Check Out Our Latest Report on Danaher
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Further Reading
- Five stocks we like better than Danaher
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
